ENACT - REACT COVID (risk assessment)

Start Date

March 2020

Duration

6 months

placeholder.jpg
placeholder_edited.jpg

Title: Registry of COVID-19 Patients at AOUI Verona (ENACT – REACT COVID)


Design: Observational cohort study


Registration Number: Institutional Review Board: 2577CESC; ClinicalTrials.gov: NCT04497194


Primary Objective: to explore epidemiological and clinical predictors of poor outcomes in COVID-19 patients admitted to University Hospital of Verona


Secondary Objective(s):

-          To identify anamnestic and laboratory predictors of early clinical progression in COVID-19 patients;

-          To provide a prediction model for early identification of COVID-19 patients at risk of developing a potentially life-threatening disease


Interested in collaboration? Contact: Elisa Gentilotti, elisa.gentilotti@univr.it


Publications


Gentilotti E, Savoldi A, Compri M, Górska A, De Nardo P, Visentin A, Be G, Razzaboni E, Soriolo N, Meneghin D, Girelli D, Micheletto C, Mehrabi S, Righi E, Tacconelli E. Assessment of COVID-19 progression on day 5 from symptoms onset. BMC Infect Dis. 2021 Aug 28;21(1):883. .

Partners

University of Verona

ID-CARE

  • Alessia Savoldi

  • Elda Righi

  • Elena Carrara

  • Elisa Gentilotti

  • Evelina Tacconelli

  • Fabio Soldani

  • Pasquale De Nardo